Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
The protein kinase, GSK-3, participates in diverse biological processes and is now recognized a promising drug discovery target in treating multiple pathological conditions. Over the last decade, a range of newly developed GSK-3 inhibitors of diverse chemotypes and inhibition modes has been develope...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2022-01-01
|
| Серии: | Frontiers in Molecular Neuroscience |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fnmol.2021.792364/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|